tetano
Editor, Senior Moderator
Curr Med Mycol
. 2021 Jun;7(2):43-47.
doi: 10.18502/cmm.7.2.7157.
Catastrophic Candida prosthetic valve endocarditis and COVID-19 comorbidity: A rare case
Lotfollah Davoodi[SUP] 1 [/SUP], Leila Faeli[SUP] 2 [/SUP], Rogheye Mirzakhani[SUP] 2 [/SUP], Rozita Jalalian[SUP] 3 [/SUP], Tahereh Shokohi[SUP] 4 5 [/SUP], Firoozeh Kermani[SUP] 5 [/SUP]
Affiliations
Abstract
Background and purpose: Coronavirus disease 2019 (COVID-19) and Candida prostatic valve endocarditis present various clinical manifestations which may overlap; hence, discrimination between them is extremely difficult.
Case report: The case was a 66-year-old man with a past medical history of mitral and aortic valves replacement one year before COVID-19 co-infection. He was admitted with fever (for 7 days), shortness of breath, cough, seizure, lethargy, headache, and 85% oxygen saturation. Transesophageal echocardiography revealed multiple large-sized, highly mobile masses on both sides of the mechanical mitral valve highly suggestive of vegetation. Chest computed tomography scanning showed simulating scattered COVID-19 peripheral ground-glass opacities confirmed by reverse-transcription polymerase chain reaction. The set of blood cultures yielded yeast colonies that were identified as Candida tropicalis. The patient died of septic shock shortly after receiving antifungal therapy.
Conclusion: This case emphasized the importance of early diagnosis and implementation of antifungal treatment, particularly in patients with prosthetic cardiac valves, to reduce their unfavorable outcomes in COVID-19 patients.
Keywords: COVID-19; Candida endocarditis; Case report; Comorbidity; Prosthetic valve replacement; SARS-CoV-2; Transesophageal echocardiography.
. 2021 Jun;7(2):43-47.
doi: 10.18502/cmm.7.2.7157.
Catastrophic Candida prosthetic valve endocarditis and COVID-19 comorbidity: A rare case
Lotfollah Davoodi[SUP] 1 [/SUP], Leila Faeli[SUP] 2 [/SUP], Rogheye Mirzakhani[SUP] 2 [/SUP], Rozita Jalalian[SUP] 3 [/SUP], Tahereh Shokohi[SUP] 4 5 [/SUP], Firoozeh Kermani[SUP] 5 [/SUP]
Affiliations
- PMID: 35028485
- PMCID: PMC8740850
- DOI: 10.18502/cmm.7.2.7157
Abstract
Background and purpose: Coronavirus disease 2019 (COVID-19) and Candida prostatic valve endocarditis present various clinical manifestations which may overlap; hence, discrimination between them is extremely difficult.
Case report: The case was a 66-year-old man with a past medical history of mitral and aortic valves replacement one year before COVID-19 co-infection. He was admitted with fever (for 7 days), shortness of breath, cough, seizure, lethargy, headache, and 85% oxygen saturation. Transesophageal echocardiography revealed multiple large-sized, highly mobile masses on both sides of the mechanical mitral valve highly suggestive of vegetation. Chest computed tomography scanning showed simulating scattered COVID-19 peripheral ground-glass opacities confirmed by reverse-transcription polymerase chain reaction. The set of blood cultures yielded yeast colonies that were identified as Candida tropicalis. The patient died of septic shock shortly after receiving antifungal therapy.
Conclusion: This case emphasized the importance of early diagnosis and implementation of antifungal treatment, particularly in patients with prosthetic cardiac valves, to reduce their unfavorable outcomes in COVID-19 patients.
Keywords: COVID-19; Candida endocarditis; Case report; Comorbidity; Prosthetic valve replacement; SARS-CoV-2; Transesophageal echocardiography.